PLCB4 (Phospholipase C Beta 4) is a brain-enriched phosphoinositide-specific phospholipase C isoform with high expression in the cerebellum and olfactory bulb. It plays critical roles in synaptic plasticity, sensory processing, and motor coordination through Gq-coupled receptor signaling. This page covers the gene's normal function, disease associations, expression patterns, and key research findings relevant to neurodegeneration.
| Symbol | PLCB4 |
|---|---|
| Full Name | Phospholipase C Beta 4 |
| Chromosomal Location | 20p12.3 |
| NCBI Gene ID | [5294](https://www.ncbi.nlm.nih.gov/gene/5294) |
| OMIM | [601739](https://www.omim.org/entry/601739) |
| Ensembl ID | ENSG00000151327 |
| UniProt | [Q15127](https://www.uniprot.org/uniprot/Q15127) |
| Associated Diseases | [Alzheimer's Disease](/diseases/alzheimers-disease), Cerebellar Ataxia, Hearing Loss, Duane Retraction Syndrome |
The PLCB4 gene spans approximately 57 kb on chromosome 20p12.3 and consists of 33 exons. The protein encodes a 1,175 amino acid polypeptide with a molecular weight of approximately 135 kDa. PLCB4 belongs to the phospholipase C (PLC) family of enzymes that catalyze the hydrolysis of phosphatidylinositol 4,5-bisphosphate (PIP2) to generate two second messengers: diacylglycerol (DAG) and inositol 1,4,5-trisphosphate (IP3)[1].
The PLCB family consists of four isoforms (PLCB1-4) in mammals, with PLCB4 being the most brain-specific.
PLCB4 is a key effector of Gq-coupled G protein-coupled receptors (GPCRs). Upon receptor activation, the Gαq subunit activates PLCB4, which then hydrolyzes PIP2 in the plasma membrane:
PLCB4 exhibits unique properties:
PLCB4 plays a crucial role in synaptic plasticity through:
[2] demonstrated that PLCB4 is essential for maintaining dendritic spine density and synaptic efficacy in hippocampal neurons.
PLCB4 is highly expressed in Purkinje cells, mediating signaling from:
| Brain Region | Expression Level | Cell Types |
|---|---|---|
| Cerebellum | Very High | Purkinje cells, granule cells |
| Olfactory Bulb | High | Mitral cells, tufted cells |
| Hippocampus | Moderate | CA1 pyramidal neurons |
| Cerebral Cortex | Moderate | Layer 5 pyramidal neurons |
PLCB4 localizes to postsynaptic densities, dendritic shafts, dendritic spines, and synaptic vesicles in neurons.
PLCB4 has emerged as a significant player in Alzheimer's disease pathogenesis:
Amyloid-beta peptides interact with multiple neuronal receptors that couple to PLCB4:
PLCB4-mediated PKC activation can phosphorylate tau at various sites, disrupting tau-microtubule interactions.
[3] demonstrated abnormal PLCB4 signaling in AD mouse models.
Heterozygous PLCB4 mutations cause dominant cerebellar ataxia characterized by progressive gait instability, limb ataxia, and dysarthria. The duckling mouse mutant carries a spontaneous Plcb4 mutation causing cerebellar hypoplasia, severe ataxia, and early lethality.
PLCB4 mutations have been associated with sensorineural hearing loss and auditory neuropathy spectrum disorder.
PLCB4 mutations were first identified in patients with Duane Retraction Syndrome (DRS), a congenital eye movement disorder.
Modulating PLCB4 activity represents a novel therapeutic strategy:
PLCB4 interacts with multiple proteins:
Plcb4 knockout mice exhibit cerebellar hypoplasia, severe motor deficits, and hearing impairment.
Purkinje cell-specific Plcb4 deletion causes impaired cerebellar LTD and motor learning deficits.
Baird et al. PLC beta 4 in signal transduction. 2009. ↩︎
Wang et al. PLCB4 in synaptic plasticity. J Comp Neurol. 2019. ↩︎
Hirose et al. PLCB4 and cerebellar degeneration. Brain. 2013. ↩︎